All Articles

The med-tech firm has submitted its AI-assisted capsule endoscopy module to the FDA, promising faster, more accurate, and accessible GI disease detection.

After eliminating over $10.7M in debt, cannabis operator LEEF Brands leverages strong Q3 growth to fuel major expansion in California and New York.

WISeKey's satellite arm, WISeSat, is merging with a SPAC to build a quantum-resilient IoT network, a key step in securing future global communications.

The regional bank sold $360M in low-yield securities, accepting a major one-time loss to reinvest for higher returns and a stronger 2026 outlook.

Daily Journal Corp's revenue soars 25% on the back of its tech arm, revealing a successful pivot and a unique model blending software and investments.

Former CEO Phil Horlock's full departure marks a new chapter for Blue Bird, which is posting record profits and accelerating its lead in electric buses.

With recent FDA approval, Belgian MedTech firm Nyxoah prepares for a pivotal presentation of its unique, battery-free sleep apnea implant at JPM.

After selling its Oklahoma assets, Amplify Energy has eliminated its debt and is now focusing its capital on high-potential Beta and Bairoil fields.

Kite Realty Group declared a special dividend for shareholders. We dig into whether this signals a healthy retail market or is simply a savvy tax strategy.

With soaring revenue and a landmark FDA approval for its Shield cancer test, Guardant Health's upcoming JPM presentation is poised to define its future.

With revenue up but clients down, Stitch Fix leadership must convince investors at the ICR conference that its AI-driven strategy can deliver growth.

The high-yield fund declared a major distribution while pivoting to safer CLO assets, signaling a new balance between aggressive income and capital preservation.

The semiconductor equipment firm will release crucial 2025 and 2026 financial guidance in January, offering a key early test of the industry's momentum.

A private tender offer values diagnostics firm PathoCare at $1.75B. Can its AI-powered, non-invasive technology justify the price and transform medicine?

For the 17th straight year, Canon U.S.A. has earned a top customer service award. We explore how they built a support dynasty in a competitive market.

XA Investments is launching a new index for credit interval funds, a move set to demystify a booming but opaque market for investors and asset managers.

Vintage Stone Capital appoints a new transaction head to accelerate its unique strategy: buying and transforming legacy industrial firms with tech, not debt.

The National Police Federation slams a report backing a provincial police force, citing high costs, low public support, and broken promises.

A new trading course blends a data expert's system with a NYSE veteran's insight. But can it tame the high-stakes world of zero-DTE options?

After resolving a cease trade order, A.I.S. Resources is set to resume trading, putting its diverse gold and lithium projects back in the market spotlight.